Damrong Tresukosol

Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24–45 years: a randomised, double-blind trial

Nubia Muñóz, Ricardo Manalastas, Punee Pitisuttithum et al. · The Lancet · 2009 · 477 citations

Gynecology, Cervical Cancer Prevention, Human Papillomavirus Vaccines +16

Phase II study of intravenous topotecan as a 5-day infusion for refractory epithelial ovarian carcinoma.

Andrzej P. Kudelka, Damrong Tresukosol, Creighton L. Edwards et al. · Journal of Clinical Oncology · 1996 · 252 citations

LINE-1 hypomethylation level as a potential prognostic factor for epithelial ovarian cancer

Jeerichuda Pattamadilok, N. Huapai, Prakasit Rattanatanyong et al. · International Journal of Gynecological Cancer · 2007 · 139 citations

Carboplatin reinduction after taxane in patients with platinum-refractory epithelial ovarian cancer.

J. J. Kavanagh, Damrong Tresukosol, Creighton L. Edwards et al. · Journal of Clinical Oncology · 1995 · 125 citations

Phase III randomized trial comparing LDR and HDR brachytherapy in treatment of cervical carcinoma

Prasert Lertsanguansinchai, Chawalit Lertbutsayanukul, Kanjana Shotelersuk et al. · International Journal of Radiation Oncology*Biology*Physics · 2004 · 120 citations

Oncology, Cervical Cancer, Radiation Therapy +6